BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 38273023)

  • 1. Lipids as mediators of cancer progression and metastasis.
    Vogel FCE; Chaves-Filho AB; Schulze A
    Nat Cancer; 2024 Jan; 5(1):16-29. PubMed ID: 38273023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implications of signaling lipids in cancer metastasis.
    Luo X; Zhao X; Cheng C; Li N; Liu Y; Cao Y
    Exp Mol Med; 2018 Sep; 50(9):1-10. PubMed ID: 30242145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lipids in cancer progression and metastasis.
    Martin-Perez M; Urdiroz-Urricelqui U; Bigas C; Benitah SA
    Cell Metab; 2022 Nov; 34(11):1675-1699. PubMed ID: 36261043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
    Mierke CT
    Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of lipids, lipid oxidation, and inflammation on AMD, and the potential role of miRNAs on lipid metabolism in the RPE.
    Jun S; Datta S; Wang L; Pegany R; Cano M; Handa JT
    Exp Eye Res; 2019 Apr; 181():346-355. PubMed ID: 30292489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lipid Side of Bone Marrow Adipocytes: How Tumor Cells Adapt and Survive in Bone.
    Diedrich JD; Herroon MK; Rajagurubandara E; Podgorski I
    Curr Osteoporos Rep; 2018 Aug; 16(4):443-457. PubMed ID: 29869753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis and Oxidative Stress in Metastatic Tumor Progression: Pathogenesis and Novel Therapeutic Approach of Colon Cancer.
    Auyeung KK; Ko JK
    Curr Pharm Des; 2017; 23(27):3952-3961. PubMed ID: 28245762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies.
    Cannon A; Thompson CM; Bhatia R; Kandy RRK; Solheim JC; Batra SK; Kumar S
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188628. PubMed ID: 34560199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid metabolism in cancer.
    Santos CR; Schulze A
    FEBS J; 2012 Aug; 279(15):2610-23. PubMed ID: 22621751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms linking pathogens-associated inflammation and cancer.
    Porta C; Riboldi E; Sica A
    Cancer Lett; 2011 Jun; 305(2):250-62. PubMed ID: 21093147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics.
    Kus K; Kij A; Zakrzewska A; Jasztal A; Stojak M; Walczak M; Chlopicki S
    Breast Cancer Res; 2018 Dec; 20(1):148. PubMed ID: 30514398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes: Key mediators of metastasis and pre-metastatic niche formation.
    Lobb RJ; Lima LG; Möller A
    Semin Cell Dev Biol; 2017 Jul; 67():3-10. PubMed ID: 28077297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid mediated brain disorders: A perspective.
    Singh A; Kukal S; Kanojia N; Singh M; Saso L; Kukreti S; Kukreti R
    Prostaglandins Other Lipid Mediat; 2023 Aug; 167():106737. PubMed ID: 37086954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory lipid mediators and insights into the resolution of inflammation.
    Lawrence T; Willoughby DA; Gilroy DW
    Nat Rev Immunol; 2002 Oct; 2(10):787-95. PubMed ID: 12360216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
    Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ
    PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumor-stromal interactions in bone metastasis.
    Esposito M; Kang Y
    Pharmacol Ther; 2014 Feb; 141(2):222-33. PubMed ID: 24140083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
    Lu J; Tan M; Cai Q
    Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.